Oxford's Arcturis and Akrivia merge in £140M deal to challenge Palantir
What's the deal? Oxford-based NHS patient data firms Arcturis DataDealroom has a profile for this one. Try Dealroom → and Akrivia HealthDealroom has a profile for this one. Try Dealroom → have agreed an all-share merger worth £140m, aiming to build greater scale against US software giant Palantir TechnologiesDealroom has a profile for this one. Try Dealroom →. The transaction is expected to complete during autumn 2026, according to Sky News.
What's the endgame? The merged group will serve 40 NHS trusts, with data on more than 20 million "in treatment" patients and 100 million aggregated patient records. Industry sources called it Britain's largest "real world" healthcare data asset, with strengths in oncology, neurology and mental health, immunology, and cardiovascular health.
Between them, the companies hold partnerships with drugmakers including AstraZenecaDealroom has a profile for this one. Try Dealroom →, Bristol Myers SquibbDealroom has a profile for this one. Try Dealroom →, GSK, Johnson & JohnsonDealroom has a profile for this one. Try Dealroom →, NovartisDealroom has a profile for this one. Try Dealroom →, and Teva.
Why now? The deal lands amid growing scrutiny of Palantir's role in UK public services. The government has reportedly revised the likely cost of the NHS England data platform built by Palantir to as much as £1.1bn while cutting expected benefits, according to the Financial Times . Palantir has also faced a row with London mayor Sir Sadiq Khan over its work for the Metropolitan Police.
One source framed the combination as a home-grown alternative. "This will be the largest sovereign NHS data aggregator and patient data health platform in the country," the source said, noting the group would be owned and domiciled in the UK.
What's changing? The management line-up remains unclear, but Akrivia chief executive David Newton is expected to hold a senior position. Alex Snow, who has led Arcturis since spearheading its rescue four years ago, is also likely to stay in a leadership role. Snow has run firms including Lansdowne PartnersDealroom has a profile for this one. Try Dealroom → and Oxford Science EnterprisesDealroom has a profile for this one. Try Dealroom →.
The merger marks another step in Arcturis's turnaround. Previously known as Sensyne HealthDealroom has a profile for this one. Try Dealroom → and founded by former science minister Lord Drayson, the company nearly collapsed in 2022 before a £26m recapitalisation. It raised £10m from funds including Lansdowne Partners and Salica InvestmentsDealroom has a profile for this one. Try Dealroom →.
Akrivia Health was spun out of the University of Oxford and the NHS in 2019, built on the Clinical Record Interactive Search (CRIS) system.
What could go wrong? The deal has yet to complete, and Arcturis declined to comment while Akrivia had not responded when contacted by Sky News.
The signal: The tie-up reflects a push for sovereign, UK-owned control of sensitive NHS data as reliance on foreign contractors draws political heat. Consolidation gives domestic players the scale to compete for a market that has become both lucrative and contentious.
Read more: Coast FM
Image credit: Generated with Gemini
